Cargando…

Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans

The endocannabinoid system (ECS) regulates various physiological processes, including energy homeostasis and kidney function. ECS upregulation in obese animals and humans suggests a potential link to obesity-induced chronic kidney disease (CKD). However, obesity-induced ECS changes in the kidney are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Permyakova, Anna, Rothner, Ariel, Knapp, Sarah, Nemirovski, Alina, Ben-Zvi, Danny, Tam, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487429/ https://www.ncbi.nlm.nih.gov/pubmed/37686443 http://dx.doi.org/10.3390/ijms241713636

Ejemplares similares

Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans
por: Rothner, Ariel, et al.
Publicado: (2023)

Cannabinoid‐1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells
por: Drori, Adi, et al.
Publicado: (2018)

Reduced Endocannabinoid Tone in Saliva of Chronic Orofacial Pain Patients
por: Haviv, Yaron, et al.
Publicado: (2022)

Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults
por: Abuhasira, Ran, et al.
Publicado: (2022)

Lower circulating endocannabinoid levels in children with autism spectrum disorder
por: Aran, Adi, et al.
Publicado: (2019)

Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles
por: Zachut, Maya, et al.
Publicado: (2018)

Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management
por: Heiliczer, Shimrit, et al.
Publicado: (2022)

Effects of Environmental Heat Load on Endocannabinoid System Components in Adipose Tissue of High Yielding Dairy Cows
por: Kra, Gitit, et al.
Publicado: (2022)

Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome
por: Knani, Ibrahim, et al.
Publicado: (2016)

Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption
por: Tartakover Matalon, Shelly, et al.
Publicado: (2021)

Effects of omega-3 supplementation on components of the endocannabinoid system and metabolic and inflammatory responses in adipose and liver of peripartum dairy cows
por: Kra, Gitit, et al.
Publicado: (2022)

Alpha-linolenic acid modulates systemic and adipose tissue-specific insulin sensitivity, inflammation, and the endocannabinoid system in dairy cows
por: Kra, Gitit, et al.
Publicado: (2023)

Hepatic targeting of the centrally active cannabinoid 1 receptor (CB(1)R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
por: Hirsch, Shira, et al.
Publicado: (2023)

Kidney Proximal Tubule GLUT2—More than Meets the Eye
por: Ahmad, Majdoleen, et al.
Publicado: (2022)

A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
por: Permyakova, Anna, et al.
Publicado: (2020)

Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
por: Chua, Janice T., et al.
Publicado: (2019)

Biomarkers of Endocannabinoid System Activation in Severe Obesity
por: Sipe, Jack C., et al.
Publicado: (2010)

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
por: Boorman, Emily, et al.
Publicado: (2015)

The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity
por: Ben-Cnaan, Elad, et al.
Publicado: (2022)

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
por: Kibret, Berhanu Geresu, et al.
Publicado: (2023)

Hypothalamic endocannabinoids in obesity: an old story with new challenges
por: Miralpeix, Cristina, et al.
Publicado: (2021)

The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure
por: Wang, Yan-Ni, et al.
Publicado: (2021)

Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice
por: Deol, Poonamjot, et al.
Publicado: (2023)

Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
por: Hirsch, Shira, et al.
Publicado: (2019)

What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
por: Schulz, Piotr, et al.
Publicado: (2021)

Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity
por: Matias, Isabelle, et al.
Publicado: (2012)

Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity
por: DiPatrizio, Nicholas V.
Publicado: (2021)

Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets
por: Laprairie, Robert B, et al.
Publicado: (2015)

Energy Metabolism Dysregulation in Chronic Kidney Disease
por: Li, Ying, et al.
Publicado: (2023)

Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent
por: Azar, Shahar, et al.
Publicado: (2020)

Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
por: Schultz, Stephen, et al.
Publicado: (2021)

Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
por: Hinden, Liad, et al.
Publicado: (2022)

Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
por: McPartland, John M.
Publicado: (2009)

The association of dietary patterns with endocannabinoids levels in overweight and obese women
por: Yagin, Neda Lotfi, et al.
Publicado: (2020)

Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019)

Cardiac calcium dysregulation in mice with chronic kidney disease
por: Ke, Hung‐Yen, et al.
Publicado: (2020)

Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss
por: Ben-Haroush Schyr, Rachel, et al.
Publicado: (2021)

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
por: Kunos, George, et al.
Publicado: (2022)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4mf1138kitqvjutdadob4iodl4